J & J Forecasts $2.5 Bln in COVID-19 Vaccine Sales This Year J & J Forecasts $2.5 Bln in COVID-19 Vaccine Sales This Year

Johnson& Johnson on Wednesday forecast $2.5 billion in 2021 sales for its COVID-19 shot and set a lower production target for the vaccine as lengthy manufacturing problems took a toll.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news